Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13Tumor-Agnostic 7Lymphoid 3Thoracic 2Genitourinary 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Sarcoma 4Sarcoma, Ewing 3Osteosarcoma 3Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Liposarcoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Leiomyosarcoma 1Hemangiosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colonic Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 11Gemcitabine 10Doxorubicin 10Cyclophosphamide 9Specimen Handling 8Nivolumab 8Ibandronic Acid 8pazopanib 7Radiosurgery 6Magnetic Resonance Spectroscopy 6Imatinib Mesylate 6Biopsy 6Bevacizumab 6Irinotecan 5regorafenib 4Zoledronic Acid 4Ipilimumab 4Ifosfamide 4Fluorouracil 4Docetaxel 4Cetuximab 4sargramostim 3conatumumab 3cemiplimab 3Sunitinib 3Radiation 3Paclitaxel 3Leucovorin 3Cryosurgery 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × abemaciclib × Sarcoma × Clear all
NCT05440786 2026-04-13

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Eli Lilly and Company

Phase 2 Active not recruiting
46 enrolled 19 charts
Sarcoma

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡